Edward Fishman: The Collapse of the Oil Empire?
EPISODE SUMMARY Podcast host Alex Gabuev is joined by Edward Fishman, a senior research scholar at the Center on Global Energy Policy at Columbia University,…
Thought Leader: Edward Fishman
By Scott Gottlieb (original source Health Affairs)
“In recent years, considerable bipartisan Congressional action, leadership from both Democratic and Republican administrations, and broad-based multistakeholder collaborations have focused on improving the tools and regulatory processes at the Food and Drug Administration (FDA), other government agencies, and public-private collaborations to support more efficient and timely development of new medical technologies. Enhanced funding through user fees and the bipartisan Twenty-First Century Cures legislation have supported a robust and better-resourced FDA and enabled science-driven collaborations in a range of areas including innovative clinical trials, “patient-focused” drug development, and greater clarity around standards for regulatory approval of new technologies.”
Click here to read more
Edward Fishman: The Collapse of the Oil Empire?
EPISODE SUMMARY Podcast host Alex Gabuev is joined by Edward Fishman, a senior research scholar at the Center on Global Energy Policy at Columbia University,…
Thought Leader: Edward Fishman
Leana Wen: How long does covid booster protection last?
More evidence highlighting the benefit, and limitations, of covid-19 vaccines. After the Centers for Disease Control and Prevention shifted its coronavirus vaccine guidance from a…
Thought Leader: Leana Wen
Dr. Sanjay Gupta: How Wearable Tech Transforms Health
We’ve come a long way in integrating technology into our daily lives, but could wearable tech actually help you live longer? From detecting heartbeat irregularities to flagging signs of…
Thought Leader: Sanjay Gupta